The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Three, two, or one drug chemotherapy for frail or elderly patients with advanced gastroesophageal cancer (321GO): A feasibility study.
Peter S. Hall
No relevant relationships to disclose
Simon Lord
No relevant relationships to disclose
Michelle Collinson
No relevant relationships to disclose
Helen Marshall
No relevant relationships to disclose
Marc Jones
No relevant relationships to disclose
Catherine Olivier
No relevant relationships to disclose
Helen Howard
No relevant relationships to disclose
Jenny Seligman
No relevant relationships to disclose
Daniel Swinson
No relevant relationships to disclose
Rajarshi Roy
No relevant relationships to disclose
Jo Dent
No relevant relationships to disclose
Sue Cheeseman
No relevant relationships to disclose
Kim William Last
No relevant relationships to disclose
Matthew T. Seymour
No relevant relationships to disclose